85 related articles for article (PubMed ID: 16637400)
1. Studies on drug metabolizing enzymes during arteether treatment of Plasmodium yoelii nigeriensis infected mice cerebral microvessels.
Agrawal A
J Commun Dis; 2005 Mar; 37(1):44-50. PubMed ID: 16637400
[TBL] [Abstract][Full Text] [Related]
2. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
[TBL] [Abstract][Full Text] [Related]
3. Status of urea and related enzymes during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Agrawal A; Tripathi LM; Pandey VC
Indian J Exp Biol; 1997 Nov; 35(11):1194-7. PubMed ID: 9567749
[TBL] [Abstract][Full Text] [Related]
4. Studies on hepatic mitochondrial cytochrome P-450 during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Srivastava P; Pandey VC
Ecotoxicol Environ Saf; 2000 May; 46(1):19-22. PubMed ID: 10805988
[TBL] [Abstract][Full Text] [Related]
5. Effect of beta-arteether treatment on erythrocytic methemoglobin reductase system in Plasmodium yoelii nigeriensis infected mice.
Srivastava S; Alhomida AS; Siddiqi NJ; Pandey VC; Puri SK
Drug Chem Toxicol; 2001 May; 24(2):181-90. PubMed ID: 11360434
[TBL] [Abstract][Full Text] [Related]
6. Studies on erythrocytic methemoglobin reductase systems in Plasmodium yoelii nigeriensis infected mice.
Srivastava S; Alhomida AS; Siddiqi NJ
In Vivo; 2000; 14(4):547-50. PubMed ID: 10945172
[TBL] [Abstract][Full Text] [Related]
7. Status of ammonia, glutamate, lactate and pyruvate during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Agarwal A; Tripathi LM; Pandey VC
J Commun Dis; 1997 Sep; 29(3):235-41. PubMed ID: 9465528
[TBL] [Abstract][Full Text] [Related]
8. Studies on hepatic oxidative stress and antioxidant defence systems during arteether treatment of Plasmodium yoelii nigeriensis infected mice.
Siddiqi NJ; Pandey VC
Mol Cell Biochem; 1999 Jun; 196(1-2):169-73. PubMed ID: 10448917
[TBL] [Abstract][Full Text] [Related]
9. Glucose transport in cerebral microvessels during Plasmodium yoelii nigeriensis infection in mice.
Agrawal A; Pandey VC
J Commun Dis; 2000 Jun; 32(2):109-16. PubMed ID: 11198395
[TBL] [Abstract][Full Text] [Related]
10. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
Awasthi A; Dutta GP; Bhakuni V; Tripathi R
Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium fragile: efficacy of arteether (alpha/beta) against cerebral malaria model.
Tripathi R; Vishwakarma RA; Dutta GP
Exp Parasitol; 1997 Nov; 87(3):290-2. PubMed ID: 9371096
[No Abstract] [Full Text] [Related]
12. Aberrations in cerebral vascular functions due to Plasmodium yoelii nigeriensis infection in mice.
Sharma MC; Tripathi LM; Rastogi M; Maitra SC; Sagar P; Dutta GP; Pandey VC
Exp Mol Pathol; 1992 Aug; 57(1):62-9. PubMed ID: 1356826
[TBL] [Abstract][Full Text] [Related]
13. New orally active derivatives of artemisinin with high efficacy against multidrug-resistant malaria in mice.
Singh C; Chaudhary S; Puri SK
J Med Chem; 2006 Nov; 49(24):7227-33. PubMed ID: 17125275
[TBL] [Abstract][Full Text] [Related]
14. Effect of Plasmodium yoelii nigeriensis infection and chloroquine on the hepatic mixed function oxidase system of mice.
Saxena N; Saxena A; Dutta GP; Ghatak S; Pandey VC
Mol Biochem Parasitol; 1987 Jul; 24(3):283-7. PubMed ID: 3627173
[TBL] [Abstract][Full Text] [Related]
15. Cerebral ammonia levels and enzyme changes during Plasmodium yoelii infection in mice.
Sharma MC; Tripathi LM; Sagar P; Dutta GP; Pandey VC
J Trop Med Hyg; 1992 Dec; 95(6):410-5. PubMed ID: 1361009
[TBL] [Abstract][Full Text] [Related]
16. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
Singh C; Malik H; Puri SK
J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
[TBL] [Abstract][Full Text] [Related]
18. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S
Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468
[TBL] [Abstract][Full Text] [Related]
19. Studies on ammonia-metabolizing enzymes during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Agrawal A; Tripathi LM; Puri SK; Pandey VC
Int J Parasitol; 1996 Apr; 26(4):451-5. PubMed ID: 8773535
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
Ma SH; Zheng L; Liu YJ; Guo SY; Feng H; Chen G; Li DM; Wang JC; Cao YM
Exp Parasitol; 2007 Jul; 116(3):266-72. PubMed ID: 17336298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
